XML 19 R3.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF INCOME - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]      
Dialysis patient service revenues $ 11,574,941 $ 11,176,464 $ 11,213,515
Other revenues 565,206 433,430 405,282
Total revenues 12,140,147 11,609,894 11,618,797
Operating expenses:      
Patient care costs 8,319,717 8,209,553 7,972,414
General and administrative 1,473,984 1,355,197 1,195,335
Depreciation and amortization 745,443 732,602 680,615
Equity investment income, net (27,864) (26,520) (26,937)
Impairment charges 26,083 0 0
Total operating expenses 10,537,363 10,270,832 9,821,427
Operating income 1,602,784 1,339,062 1,797,370
Debt expense (398,551) (357,019) (285,254)
Debt Extinguishment And Modification Costs (7,962) 0 0
Other (loss) income, net (19,177) (15,765) 6,378
Income from continuing operations before income taxes 1,177,094 966,278 1,518,494
Income tax expense 220,116 198,087 306,732
Net income from continuing operations 956,978 768,191 1,211,762
Net income from discontinued operations, net of tax 0 13,452 0
Net income 956,978 781,643 1,211,762
Less: Net income attributable to noncontrolling interests (265,443) (221,243) (233,312)
Net income attributable to DaVita Inc. $ 691,535 $ 560,400 $ 978,450
Earnings per share attributable to DaVita Inc.:      
Basic net income from continuing operations $ 7.62 $ 5.88 $ 9.30
Basic net income 7.62 6.03 9.30
Diluted net income from continuing operations 7.42 5.71 8.90
Diluted net income $ 7.42 $ 5.85 $ 8.90
Weighted average shares for earnings per share:      
Basic shares (in shares) 90,790,000 92,992,000 105,230,000
Diluted shares (in shares) 93,182,000 95,834,000 109,948,000
Amounts attributable to DaVita Inc.:      
Net income from continuing operations $ 691,535 $ 546,948 $ 978,450
Net income from discontinued operations 0 13,452 0
Net income attributable to DaVita Inc. $ 691,535 $ 560,400 $ 978,450